Spectral AI FY2025 EPS Estimate Decreased by Northland Capmk

Spectral AI, Inc. (NASDAQ:MDAI) – Equities research analysts at Northland Capmk decreased their FY2025 earnings per share estimates for shares of Spectral AI in a research report issued to clients and investors on Wednesday, November 12th. Northland Capmk analyst C. Byrnes now forecasts that the company will earn ($0.44) per share for the year, down from their prior estimate of ($0.35). The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share. Northland Capmk also issued estimates for Spectral AI’s Q4 2025 earnings at ($0.14) EPS and FY2026 earnings at ($0.45) EPS.

Spectral AI (NASDAQ:MDAI) last issued its quarterly earnings results on Tuesday, November 11th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.05). The business had revenue of $3.79 million for the quarter, compared to analysts’ expectations of $5.06 million. Spectral AI has set its FY 2025 guidance at EPS.

Other equities analysts also recently issued reports about the stock. Wall Street Zen downgraded shares of Spectral AI from a “hold” rating to a “strong sell” rating in a report on Saturday, August 16th. Weiss Ratings reissued a “sell (e+)” rating on shares of Spectral AI in a report on Friday, October 31st. Finally, BTIG Research cut their price objective on shares of Spectral AI from $3.50 to $3.00 and set a “buy” rating for the company in a research report on Wednesday. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $3.25.

Spectral AI Price Performance

Shares of MDAI opened at $1.65 on Friday. The company has a market cap of $50.64 million, a PE ratio of -2.23 and a beta of 0.91. The firm has a 50-day moving average of $2.16 and a 200-day moving average of $2.08. Spectral AI has a one year low of $1.01 and a one year high of $3.25.

Institutional Investors Weigh In On Spectral AI

A number of large investors have recently added to or reduced their stakes in the stock. Philip James Wealth Mangement LLC bought a new position in Spectral AI in the 3rd quarter valued at about $27,000. Jane Street Group LLC bought a new stake in shares of Spectral AI during the 2nd quarter worth approximately $74,000. Marshall Wace LLP acquired a new stake in shares of Spectral AI during the 2nd quarter worth approximately $104,000. DNB Asset Management AS acquired a new stake in shares of Spectral AI during the 2nd quarter worth approximately $107,000. Finally, XTX Topco Ltd bought a new position in Spectral AI in the second quarter valued at approximately $123,000. Institutional investors and hedge funds own 67.08% of the company’s stock.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.